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Abstract
Background and Objective Children with inherited metabolic diseases often require complex and highly specialized care.
Patient and family-centered care can improve health outcomes that are important to families. This study aimed to examine
experiences of family caregivers (parents/guardians) of children diagnosed with inherited metabolic diseases with healthcare
to inform strategies to improve those experiences.
Methods A cross-sectional mailed survey was conducted of family caregivers recruited from an ongoing cohort study. Participants rated their healthcare experiences during their child’s visits to five types of healthcare settings common for inherited
metabolic diseases: the metabolic clinic, the emergency department, hospital inpatient units, the blood laboratory, and the
pharmacy. Participants provided narrative descriptions of any memorable negative or positive experiences.
Results There were 248 respondents (response rate 49%). Caregivers were generally very or somewhat satisfied with the care
provided at each care setting. Appropriate treatment, provider knowledge, provider communication, and care coordination
were deemed essential aspects of satisfaction with care by the majority of participants across many settings. Memorable
negative experiences were reported by 8–22% of participants, varying by setting. Among participants who reported memorable negative experiences, contributing factors included providers’ demeanor, lack of communication, lack of involvement
of the family, and disregard of an emergency protocol letter provided by the family.
Conclusions While caregivers’ satisfaction with care for children with inherited metabolic diseases was high, we identified
gaps in family-centered care and factors contributing to negative experiences that are important to consider in the future
development of strategies to improve pediatric care for inherited metabolic diseases.

1 Background
Inherited metabolic diseases (IMD) are a group of rare single-gene diseases frequently diagnosed early in life that have
a collective prevalence of approximately 50.9 per 100,000
live births [1]. Children with IMD often require complex
and specialized care [2–4]. Across a variety of diseases,
settings, and patient populations, patient experience with
care is associated with clinical and safety outcomes [5] and
is recognized as key to a high-quality health system [6].
Principles of patient-centered care, including accessible
* Beth K. Potter
bpotter@uottawa.ca
Extended author information available on the last page of the article

services, respect, clear communication, and coordination
and continuity of care [7–9], often form the basis of assessments of patient experience [10]. In pediatrics, the concept
of patient-centered care is extended to family-centered care,
emphasizing children’s developmental needs and the central
role of families [11, 12].
Aspects of healthcare shown to be important to the experiences of children with chronic conditions and their families
include care coordination [11–13] and perceived empathy
of healthcare providers [14]. However, few studies have
examined healthcare experiences for children with IMD
specifically [15–18]. In our previous qualitative study in this
population, while parents/guardians reported positive care
experiences within the pediatric metabolic clinic, they often
expressed dissatisfaction with care in non-IMD-specific
Vol.:(0123456789)
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Key Points
This study identifies several elements of care that contribute to parents’ satisfaction with healthcare across five
healthcare settings commonly visited by children with
inherited metabolic diseases (IMD), including receipt of
appropriate treatment, provider knowledge and communication, and coordinated care.
While generally satisfied with care, parents of children
with IMD reported recent memorable negative experiences with their child’s healthcare, particularly in the
emergency department and during hospitalization. These
negative experiences were often related to poor provider
demeanor, lack of communication, poor involvement of
the family, and disregard of emergency protocol letters.
Our findings provide an important foundation for understanding where gaps in family-centered healthcare are
for children with IMD, informing the development of
interventions and strategies to address those gaps and
ultimately improve healthcare for children with IMD.
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research were eligible to participate. Between 20 January,
2017 and 18 July, 2018, participants were invited to complete a one-time cross-sectional questionnaire. Participants
with multiple children in the cohort were invited to complete
the survey for their oldest child in the cohort. All eligible
families were contacted by mail up to four times using an
approach adapted from Dillman [19]: they were mailed a
pre-notification letter to inform them of the study, an invitation to participate along with the questionnaire, and two
reminder messages with replacement questionnaires. Consent was implied with completion and return of the questionnaire by mail, in pre-paid envelopes.

2.3 Questionnaire Development
Questionnaire content and instrument selection were
informed by previous qualitative studies [17, 20] and a scoping review [21]. Minor changes to the questionnaire were
made following a pilot test with six parents of children with
an IMD using cognitive telephone interviews [22], whereby
participants answered the questionnaire by verbally describing their thought process.

2.4 Measures
healthcare settings, such as the pharmacy, emergency department, and blood laboratory. These negative experiences
tended to stem from interactions with providers unfamiliar
with a child’s diagnosis and/or coordination and communication of services [17]. To better understand and inform
strategies to improve care, this study examines experiences
with healthcare among a larger sample of children diagnosed
with IMD from the perspectives of their caregivers.

2 Methods
2.1 Ethical Considerations
Ethics approval for this study was obtained from the
Research Ethics Boards of Children’s Hospital of Eastern
Ontario, Ottawa Health Science Network and participating
centers.

2.2 Participants and Study Design
Participants were parents or guardians (“caregivers”, one
per household) recruited from an ongoing cohort study of
children born between 2006 and 2015 with a confirmed diagnosis of one of 31 IMD (Electronic Supplementary Material
[ESM]), receiving treatment from one of 13 participating
pediatric metabolic clinics, all located at major Canadian
hospitals. Caregivers who had agreed to be re-contacted for

2.4.1 Child and Family Characteristics
We collected data on participant and household-level characteristics, such as annual gross household income, home
community size, gender identity, relationship to the child,
employment status, and attained education. Child’s sex, birth
year, and IMD were linked from the cohort study. We also
collected data on typical mode of travel and travel time from
a participant’s home to the metabolic clinic.
2.4.2 Care Experiences
Participants were asked how many times, in the past year,
they had visited each of five healthcare settings for their
child’s care: metabolic clinic, blood laboratory, emergency
department, hospitalizations, and pharmacy. For each setting visited at least once, participants were asked to rate
their overall satisfaction with care on a five-point scale,
from “very dissatisfied” to “very satisfied”. Participants
then selected factors that they considered essential to their
satisfaction rating from a list of options tailored to each setting. Next, participants were asked, “In the past year, have
you had an experience at [setting] for your child’s care that
was either so positive or so negative, you were still thinking about it one week later?”. If “yes”, participants indicated whether the experience was positive or negative, and
were invited to provide a brief narrative description of that
experience.
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We measured caregiver perceptions of care coordination
for their child by adapting the Family Experiences with Care
Coordination Survey [23]. Participants were asked to identify the provider they considered to be their child’s main
provider, defined as the person “who knows the most about
your child’s health, and who is in charge of your child’s care
overall,” and then asked questions related to their experiences with: getting help to manage their child’s care; care
from specialists and receipt of community services; and visit
summaries and care plans.
The metabolic clinic plays a significant role in the healthcare of most children with an IMD. We measured participants’ perceptions of the overall care that their child received
at the metabolic clinic over the previous year using the validated Measures of Processes of Care (MPOC-20) instrument
[24]. The MPOC-20 assesses the extent to which healthcare
services are family centered and consists of five subscales:
enabling and partnerships; providing general information;
providing specific information; coordinated and comprehensive care; and respectful and supportive care. Scores range
from 1 to 7 with higher scores indicating that a provider or
clinic exhibits a behavior/activity to a greater extent.

2.5 Data Analysis
We entered survey data in duplicate and compared entries;
differences were resolved by consensus. Survey data were
stored using Research Electronic Data Capture (REDCap)
[25, 26] and analyzed using Microsoft Excel and SAS software (Version 9.4; SAS Institute Inc., Cary NC, USA).
Analyses were primarily descriptive. Data for three variables were grouped during analysis (Table 1). We calculated proportions for categorical variables and medians
Table 1  Groupings of
categorical variables

Variable grouping
Satisfaction with care
Satisfied
Non-satisfied
Community size
Larger communities

and interquartile ranges for continuous variables. We used
an inductive process to code narrative descriptions for the
aspects of care that contributed to participants’ memorable
experiences. Briefly, one author (MP) reviewed the narrative
data and assigned codes to each description, and a second
author (AC) verified the coding. AC, MP, and BKP collaborated to group the codes into higher order themes.
We also conducted exploratory post-hoc stratified analyses to describe satisfaction with care at each setting by: community size (larger vs smaller); child age group (≥ 5 vs < 5
years); and visit frequency. We stratified by community size
given the well-known barriers associated with access to specialist care in rural areas [27, 28]. We stratified by child age
given the different healthcare needs at different ages, which
we reasoned could have an important impact on family experiences. Finally, we speculated that more frequent visitors
may be more familiar with a setting and able to navigate
concerns more easily, but also that negative experiences may
accumulate with visit frequency. We calculated 95% confidence intervals for each proportion but, given their post-hoc
nature and the number of stratifications and settings, we did
not conduct hypothesis tests for these exploratory analyses.
For the metabolic clinic, we used non-parametric tests of
significance (Mann–Whitney U or Kruskal–Wallis test) to
investigate differences in MPOC-20 scores associated with
satisfaction with care at the metabolic clinic (satisfied vs
non-satisfied), community size, and travel time to the clinic
(categories from < 30 min to > 2 h). Because of small numbers, we did not analyze satisfaction by IMD. However, as
a sensitivity analysis, we described satisfaction with care
among a subgroup of participants whose children received
care at four to five healthcare settings, as a proxy for high
healthcare needs. We also conducted a post-hoc descriptive

Variable categories
Somewhat satisfied
Very satisfied
Neither satisfied nor dissatisfied
Somewhat dissatisfied
Very dissatisfied

Large city (population of ≥ 100,000 people)
Medium-sized city (population of ≥ 30,000 and < 100,000 people)
Smaller communities
Small community (population of ≥ 1000 and < 30,000 people)
Rural area (population of < 1000 people)
Frequency of healthcare visits over past year
Fewer
1–2 times (metabolic clinic, emergency department, blood laboratory)
Once or less than once per month (pharmacy)
Once (hospitalizations)
More
3 or more times (metabolic clinic, emergency department, blood laboratory)
At least once per month (pharmacy)
2 or more times (hospitalizations)
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analysis of satisfaction with care by memorable positive or
negative experiences. Missing data were minimal (< 3%)
and were handled using casewise deletion.

3 Results
At the time of study recruitment, 536 children had been
enrolled in the cohort study. Valid mailing addresses and
consent to be re-contacted for future studies were available
for 509 children; their caregivers were invited to participate
in the survey. Of those invited, 248 caregivers completed and
returned questionnaires, a response rate of 49%. Children
of survey respondents were similar to the full cohort in sex,
age, and IMD (data not shown). Most questionnaires (84%)
were completed by a female biological parent (Table 2).
Nearly half of participants (48%) reported traveling 1 hour
or more to reach the clinic. Close to half of the children
were diagnosed with either medium-chain acyl-CoA dehydrogenase deficiency (23%) or phenylalanine hydroxylase
deficiency (23%).

3.1 Satisfaction with Care
Most participants visited the metabolic clinic (n = 230,
93%), a hospital or community-based blood laboratory (n
= 208, 84%), or a pharmacy (n = 174, 70%) at least once in
the previous year for their child’s care. A minority visited
the emergency department (n = 80, 32%) or were hospitalized (n = 46, 19%).
Satisfaction with care was generally high among participants (Table 3), with ratings from 78 to 84% satisfied at the
metabolic clinic, pharmacy, and blood laboratory. A slightly
smaller proportion of participants were satisfied with care
provided during hospitalization (n = 32, 70%) and at the
emergency department (n = 55, 69%). The proportion of
participants satisfied with care at the metabolic clinic was
somewhat smaller among those living in smaller (n = 49,
77%) vs larger (n = 143, 88%) communities. While there
were also differences across strata based on community size
and visit frequency at the emergency department and during
hospitalization, these exploratory analyses were based on
small numbers.

3.2 Contributors to Satisfaction Ratings
Providers’ attitudes and communication with families were
rated as essential or very important to levels of satisfaction
with care by ≥ 88% of participants across all settings and by
≥ 95% at settings with physician-led care (metabolic clinic,
emergency department, and hospital inpatient units) (Fig
1a–e). Appropriate treatment and provider knowledge were
considered essential to reported satisfaction by ≥ 75% of
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Table 2  Participant, household, and child characteristics
No. (%)a
Participant characteristics
Gender and relationship to childb (n = 246)
Female, biological parent
Age, years (n = 247)
20–29
30–39
40 or older
Working part/full time (n = 247)c
Highest education level completed (n = 243)
High school or less
Vocational/technical training
College/university
Graduate school
Household characteristics
Community size (n = 244)
Large city (≥100,000 people)
Medium city (30,000–100,000 people)
Small community (1000–30,000 people)
Rural or very small community (<1000 people)
Household income (n = 235)
< $40,000
$40,000–$59,999
$60,000–$79,999
$80,000–$99,999
$100,000 or more
Distance from home to the metabolic clinic (n = 230)d
< 30 min
30 min to < 1 h
1–2 h
>2h
Mode of transportation to metabolic clinic (n = 230)d
Personal vehicle
Public transit or other
Child characteristics (n = 248)
Assigned sex, f emalee
Birth year
2005–7
2008–9
2010–11
2012–13
2014–15
Inherited metabolic disease
Medium-chain acyl-CoA dehydrogenase deficiency
Phenylalanine hydroxylase deficiency
Organic acid disorders
Galactosemia
Multiple carboxylase deficiency or biotinidase deficiency
Other fatty acid oxidation disorders
Other amino acid disorders

207 (84)
20 (8)
124 (50)
103 (42)
179 (72)
35 (14)
18 (7)
147 (60)
43 (18)

130 (53)
42 (17)
54 (22)
18 (7)
26 (11)
24 (10)
23 (10)
38 (16)
124 (53)
55 (24)
65 (28)
72 (31)
38 (17)
216 (94)
14 (6)
127 (51)
50 (20)
45 (18)
36 (15)
53 (21)
64 (26)
56 (23)
56 (23)
24 (10)
15 (6)
32 (13)
24 (10)
12 (5)
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Table 2  (continued)
a

No. (%)
Other disorders
a
b

29 (12)

Valid percentages presented

Remaining participants were male or other gender and/or other relationship to child
c

d

Remaining participants were not working or looking for work

Only participants who had visited the metabolic clinic for their
child’s care in the past year were asked this question
e

Remaining participants were male or undetermined

participants at settings where care was physician led. Coordination of care with other providers was considered essential by > 60% of visitors to these settings, especially visitors
to hospital inpatient units (82%). Attention to non-medical
needs was considered essential by a minority of participants
at all settings.
The only factors rated as essential to satisfaction with
blood laboratory care by a majority of participants were
care provider attitudes (68%) and communication with the
child/caregiver (54%). At the pharmacy, more than 70% of
participants identified factors related to the timely, correct
acquirement of required products as essential to their satisfaction with care.

3.3 Memorable Experiences
A minority of participants reported a memorable positive or
negative experience at any setting in the past year (Fig. 2).
The proportion of participants with a memorable positive
experience ranged from 10% (pharmacy) to 17% (hospital
inpatient unit) of participants whose child visited the queried
setting in the past year. Comparable proportions of participants had a memorable negative experience, with a range
from 8% at the pharmacy to 22% during hospitalizations.
In narrative descriptions of memorable experiences, qualitative themes differed by setting (Table 4). Provider/staff
demeanor was reported to contribute to positive/negative
experiences at all settings except the emergency department.
Good or poor communication with the family by providers/
staff contributed to several memorable experiences at the
metabolic clinic. At the emergency department, receipt of
timely treatment or care and perceived coordination among
providers/staff coordinating contributed to some positive
experiences, whereas aspects of care contributing to negative experiences included providers/staff not following an
emergency protocol letter supplied by the family and providers/staff lacking relevant skills or knowledge. Wait times
for care or products contributed to memorable experiences
at the blood laboratory and the pharmacy. Multiple blood
draw attempts and errors in filling product orders contributed

Table 3  Satisfaction with healthcare for children with inherited metabolic diseases by health service setting
Satisfieda with care at
Metabolic clinic
Overall
Stratified by community sizec
Larger
Smaller
Stratified by visit frequencyd
Fewer
More
Stratified by age group, y earse
<5
≥5
Emergency department
Overall
Stratified by community sizec
Larger
Smaller
Stratified by visit frequencyd
Fewer
More
Stratified by age group, y earse
<5
≥5
Blood laboratory
Overall
Stratified by community sizec
Larger
Smaller
Stratified by visit frequencyd
Fewer
More
Stratified by age group, y earse
<5
≥5
Hospitalization
Overall
Stratified by community sizec
Larger
Smaller
Stratified by visit frequencyd
Fewer
More
Stratified by age group, y earse
<5
≥5
Pharmacy
Overall
Stratified by community sizec
Larger

n/N

% (95%
confidence
interval)b

194/230

84 (79–89)

143/163
49/64

88 (82–92)
77 (65–86)

149/178
45/52

84 (78–89)
87 (75–94)

82/97
112/133

85 (76–91)
84 (77–90)

55/80

69 (58–78)

43/60
10/18

72 (59–82)
56 (33–77)

45/62
10/18

73 (61–83)
56 (33–77)

28/37
27/43

76 (60–87)
63 (48–76)

162/208

78 (72–83)

114/148
46/57

77 (70–83)
81 (69–89)

107/138
55/70

78 (70–84)
79 (68–87)

62/84
100/124

74 (64–82)
81 (73–87)

32/46

70 (55–82)

25/34
5/10

74 (57–86)
50 (21–79)

21/32
11/14

66 (48–80)
79 (52–94)

20/25
12/21

80 (61–92)
57 (36–77)

138/174

79 (73–85)

103/129

80 (72–86)
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Table 3  (continued)
Smaller
Stratified by visit frequencyd
Fewer
More
Stratified by age group, y earse
<5
≥5

33/42

79 (64–89)

102/128
35/45

80 (72–86)
78 (64–88)

60/73
78/101

82 (72–90)
77 (68–85)

Study participants who had not visited the care setting at least once in
the past year were excluded from analysis

a

Self-reported; defined as “very satisfied” and “somewhat satisfied”.
Remaining participants were non-satisfied (neither satisfied nor dissatisfied, somewhat dissatisfied, or very dissatisfied)

b
c

Mid-P Exact Test

“Larger” defined as “large city” and “medium-sized city”; “smaller”
defined as “small community” and “rural area”

From analyses of the IMD diagnoses of children who visited the emergency department and hospital inpatient units
(ESM), we found that diagnoses among children with one
visit to the emergency department were quite variable; those
visiting three or more times most often had a diagnosis characterized by a risk of acute exacerbations. Children who
were hospitalized at least once tended to have IMD diagnoses characterized by a risk of acute crises and/or complex
multi-system manifestations. Among participants reporting
memorable positive or negative experiences, although data
were sparse, descriptively, a smaller proportion of participants reporting a negative memorable experience at a setting
in the past year reported being satisfied with care at that
setting (30–37%, setting dependent) relative to participants
with positive memorable experiences (from ~63% to 97%,
setting dependent).

d

“Fewer” defined as, over the past year: 1–2 times for metabolic
clinic, emergency department, blood laboratory; 1 time to less than
once per month for the pharmacy; 1 time for hospitalizations. “More”
defined as: 3 or more times for metabolic clinic, emergency department, blood laboratory; at least once per month for pharmacy; 2 or
more times for hospitalizations
e

Age group defined at time of questionnaire mailout

to several negative experiences at the blood laboratory and
pharmacy, respectively.

3.4 Family‑Centered Care
Participants reported that their child’s healthcare services
at the metabolic clinic were family centered to a fairly great
(score of 5) or great (score of 6) extent for all but one subscale of the MPOC-20 (Table 5). The median score for the
“Providing General Information” subscale (capturing the
extent to which providers shared information and resources
about the IMD and available services) was 4.00. Participants
who reported non-satisfaction with metabolic clinic care
had statistically significantly lower median scores across all
MPOC-20 subscales compared with those reporting satisfaction. Participants living in larger communities had a higher
median score (p = 0.045) on the “Enabling and Partnership”
subscale (capturing the extent to which participants felt they
had the opportunity to participate in decision making) than
those living in smaller communities. There were no significant differences associated with travel time for any MPOC20 subscale.

3.5 Sensitivity Analyses
The proportion of participants who were satisfied with care
at each setting among those whose children accessed care at
four to five settings (proxy for higher healthcare needs) was
comparable to the proportion for the total sample (ESM).

3.6 Main Providers, Care Coordination,
and Community Service Use
The majority of participants (n = 141, 57%) identified a
metabolic clinic provider as their child’s main healthcare
provider, 27% (n = 67) identified a family physician, and
12% (n = 30) identified a non-metabolic pediatrician. A
minority reported that the main provider had provided them
with a written visit summary for at least one visit in the past
year (32%) or created a shared care plan for the child (11%);
almost half (47%) did not know whether they had a shared
care plan.
Approximately half of the participants (126/245, 51%)
reported that their child used multiple types of health services in the past year, of whom 58% (n = 71) received support to coordinate those services (Table 6). Of caregivers
receiving care coordination support, 78% (n =53) received
support from someone associated with their child’s main
provider. Fifty participants (20%) reported that they or
their child needed or used community services for IMD
care (Table 6), of whom 40% had problems accessing these
services.

4 Discussion
Caregivers of children with IMD participating in this study
were generally satisfied with the care their child received
across a range of settings and factors considered essential to care and were quite similar across settings. Direct
comparisons of satisfaction ratings across settings should
be avoided; satisfaction may be influenced not only by the
quality of care provided but also by other factors such as
the urgency of care required, providers’ specialized knowledge of the child’s condition, and the degree of familiarity
between the family and a setting’s care providers. However,
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Fig. 1  a Importance of factors contributing to caregiver
satisfaction with metabolic
clinic care. b Importance of
factors contributing to caregiver
satisfaction with emergency
department care. c Importance
of factors contributing to caregiver satisfaction with blood
laboratory care. d Importance
of factors contributing to caregiver satisfaction with hospital
inpatient care. e Importance of
factors contributing to caregiver
satisfaction with pharmacy
services. HCP healthcare
practitioner

a

85%

Appropriate treatment for child's problems

15%

82%

HCP knowledge about child's needs

17%

76%

HCP communication with caregiver/child

22%

66%

HCP attitudes

Communication/coordination between HCP

30%

63%

32%

43%

Amount of time HCP spent with caregiver/child
21%

Wait time to see a HCP once at the clinic

23%

15%

Wait time to get an appointment

23%

10%

38%
36%

10%

Attention to non-medical needs

13%

46%

15%

Clinic location in relation to home

5%

43%

23%
30%

19%

19%

50%

20%

% of participants (n=230)
Data labels <5% not shown. HCP = health care provider

b

Essential

Very important

Not important

6%

94%

Appropriate treatment for child's problems

28%

71%

HCP attitudes

70%

Communication/coordination between HCP

69%

26%
29%

19%

39%

25%

18%

6%

34%

59%

Wait time to see a HCP

8%

25%

65%

Management of child's pain

5%

20%

75%

HCP knowledge about child's needs
HCP communication with caregiver/child

Attention to non-medical needs

Somewhat important

% of participants (n=80)
Essential

Data labels <5% not shown. HCP=health care provider

c

Management of child's pain

42%
41%

21%

24%

33%

22%

7%
8%

25%

40%

19%

41%

22%

% of participants (n=207)
Essential

Very important

Somewhat important

Not important

7%

91%

11%

87%

HCP knowledge about child's needs

16%

82%

Communication/coordination between HCP

17%

78%

HCP attitudes

22%

76%

HCP communication with caregiver/child

24%

67%

Management of child's pain

Duration of hospital stay

28%

Attention to non-medical needs

28%

26%

28%

39%

Coordination with services (e.g. food, pharmacy)

some commonalities could be seen in our results. Provider
communication with the family, a key principle of familycentered care, was considered essential to satisfaction with
care by the vast majority of participants across all settings,
as was provider attitudes. Appropriate treatment, provider
knowledge, and coordination were considered essential by

17%
16%

48%

Appropriate treatment for child's problems

Valid % shown. Each factor was rated by >= 43
participants. Data labels <5% not shown.
HCP=health care provider

14%
22%

27%

18%

Valid % shown. Each factor was rated by >= 203
participants. Data labels <5% not shown.
HCP=health care provider

19%

43%

27%

Wait time to receive test results

10%

35%

29%

Hours of operation

6%

26%

34%

Complications/side effects of blood draw

Amount of blood needed

Not important

34%

54%

Wait time to have blood drawn

Attention to non-medical needs

Somewhat important

68%

HCP attitudes
HCP communication with caregiver/child

d

Very important

7%

30%

37%
30%

7%

33%

9%

% of participants (n=46)
Essential

Very important

Somewhat important

Not important

most participants visiting settings with physician-led care
(metabolic clinic, hospitalizations, emergency department).
These factors were echoed in the qualitative findings regarding memorable experiences. Among participants reporting a
memorable negative experience in the past year, providers’
demeanor, lack of communication, lack of involvement of
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% of participants (n=172)
Valid % shown. Each factor was rated by >=
149 participants. Data labels <5% not shown

Fig. 2  Number and percent of
participant-reported memorable
experiences over the past year,
at various healthcare settings
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Very important

Somewhat important
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13%

150

100
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15
13

50

52
0

Metabolic clinic
n=229

19%
16%

30

15%

26

13%

150

73%

28

Emergency department
n=80

Blood laboratory
n=206

8%

17

10%

141
10
8

65%

13

82%

22%
17%
61%

Hospitalization
n=46

Pharmacy
n=171

Health care setting
No memorable experience

the family, or disregard of an emergency protocol letter were
frequently mentioned factors contributing to those experiences at physician-led care settings. These findings are consistent with the literature on important contributors to the
healthcare experiences of children with chronic conditions
and their families [11–14].
Our post-hoc sensitivity analysis indicated that participants with memorable positive experiences at a setting
were likely to be satisfied with care provision at that setting while those with negative experiences were likely to be
non-satisfied. The numbers were small and data are crosssectional; causality is difficult to assess. We speculate that
a memorable experience may influence participants’ overall
satisfaction ratings; if so, attention to the aspects of care
related to memorable experiences could improve satisfaction. Family-centered care must, however, be tailored to specific settings [11]. The settings where the largest proportions
of participants reported a negative experience were hospital

Memorable positive experience

Memorable negative experience

inpatient units (22%) and the emergency department (19%).
These settings are related: most of the participants (40/46)
whose children were hospitalized at least once in the past
year also had at least one visit to the emergency department
(data not shown). Children who were hospitalized and/or
who experienced three or more emergency department visits
in the past year often had IMD diagnoses characterized by
a risk of acute exacerbations. However, because of small
numbers, we were not able to analyze associations between
specific IMD and satisfaction ratings. Emergency department visits and hospitalizations for acute exacerbations can
be very stressful for caregivers [29, 30]; we speculate that
the stresses associated with the child’s need for acute care
may influence their caregivers’ satisfaction with care but
we were not able to directly evaluate this within our data. In
our previous study of caregivers of children with IMD [17],
some caregivers felt that emergency department providers
were not adequately familiar with IMD-specific care and
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Table 4  Most frequently coded aspects of care related to memorable experiences, by healthcare setting, and example quotations
Setting
Experience type
Code
Metabolic clinic
Positive experience
HCP/staff had positive demeanor
HCP/staff communicated well
HCP/staff involved the family in care
Negative experience
Poor follow-up care/communication
HCP/staff did not communicate well
Child did not receive timely treatment or care
HCP/staff lacked relevant skills/knowledge

HCP/staff had negative demeanor

Emergency department
Positive experience
Child received timely treatment or care
HCP/staff coordinated well with each other
Negative experience
HCP/staff did not follow the emergency protocol letter
HCP/staff lacked relevant skills/knowledge
HCP/staff did not involve the family in care

n (%)

Example quotation

N = 29
12 (41) Every time we go they are so welcoming and make you feel comfortable. I couldn’t ask for a better team
11 (38) My son’s care providers answer all of our questions patiently and
professionally
5 (17) I’m always so appreciative how ‘my team’ includes each of us (family
of 4) in the care for my son (only one of us is the actual patient)
N = 25
6 (24) We are disappointed that each time our daughter has her bloodwork
done that we have to chase the team for results (>1 month after) even
when results were abnormal
5 (20) [The] dietician first appointed [was] very poor in answering basic
dietary questions; [I] felt ‘disregarded’ with any of my concerns my
child’s health and dietary needs
4 (16) Long wait time (2.5 hrs) from start to finish of appointment […] not
really feeling as if anything was accomplished
4 (16) I asked the physician to examine my child’s feet, which had several
problems: fungal nail infection, athlete’s foot, flaking. He told me:
‘It’s nothing, there’s nothing we can do for that.’ Fortunately I consulted another physician who took good care of all the health issues
my child has
4 (16) The initial call I received when she was two days old still lingers in my
memory. I was told to come to the hospital because my daughter has
been identified through newborn screening as being mentally slow.
Sensitivity during the initial call was lacking
N = 13
5 (38) We didn’t wait too long in the emergency room. The metabolic doctor
on call informed ER that my son who is metabolic is coming & there
is no time to wait. Every minute is crucial
3 (23) The communication and coordination between the genetics team and
the emergency doctor were very satisfying
N = 15
5 (33) Trauma situation with my child. Emergency room doctor refused to follow instructions for her care set out by the metabolic’s team. I had to
call [Hospital] before care changed
4 (27) There was a major delay in treatment because of doctor lack of knowledge about disorder
3 (20) I told the staff that her CK’s (creatine kinase) were up & they refused
to […] listen to me until her CK’s came back at 60,000
3 (20) Waiting 12 hours to be admitted and get our room

Wait time was too long
Blood laboratory
Positive experience
N = 26
HCP/staff provided physical/emotional comfort to the child 14 (54) Nurses were very good with my child. They made [child] feel very
comfortable even though [child] does not enjoy needles
HCP/staff had positive demeanor
12 (46) All lab technicians have been very sympathetic and caring. Very
patient and understanding. Amazing staff
HCP/staff had relevant skills/knowledge
6 (23) The technician never misses the vein
Negative experience
N = 30
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Table 4  (continued)
Setting
Experience type
Code
Multiple blood draw attempts

Wait time was too long
Blood draw was not done correctly/successfully
Hospitalization
Positive experience
HCP/staff had positive demeanor

Negative experience
HCP/staff had negative demeanor
Pharmacy
Positive experience
Received product in a timely manner
HCP/staff exceeded the expectations of their role

HCP/staff had positive demeanor
Negative experience
Did not receive product in a timely manner
Errors made in filling the order

n (%)

Example quotation

14 (47) I am still thinking about it 1-1.5 years later […] One time she was in
for 45 minutes, they tried 3 times as she was screaming away and
failed to collect the sample after the third [time] so we had to come
back 3 days later. She was bruised all up her arms. It haunts me to
this day
7 (23) Kids have already been fasting for hours when we arrive at the lab and
then the wait is almost always another hour
5 (17) Having to dig in her arm for over a minute with the wrong size + being
unsuccessful. Then trying 2 more times in 2 different places finally
with the correct needle size
N=8
3 (38)

Seeing the same staff who [...] remember us and are comfortable communicating with us make hospital stays positive and easy - sometimes
fun. Staff not assigned to us or at the end of shifts dropping in to say
hi and check on us also help when in isolation and [it’s] hard to leave
[the] room

N = 10
3 (30) The metabolic intern was arrogant […] Also he kept pushing my child
to eat - to the point of nearly shaming her. She was very nauseous
with rotavirus

N = 17
7 (41) Knowing that our child needs the medication, they now stock a small
amount and, when ordered, will get it within a couple of days, notifying us when it arrives
6 (35) Our local pharmacy is a compounding pharmacy; they did an excellent
job researching the drugs use in order to not have ‘phe’ contained in
our [child]’s prescription. The pharmacy technician also uploaded
a page from the ‘PKU Food List book’ which lists drugs containing
Phe. It is recorded on my [child]’s file as a caution that she has PKU
‘NO ASPARTAME’
6 (35) Pharmacy staff treated us like family […] Their attitude was extremely
friendly and they went out of their way to be helpful
N = 13
8 (62) I have found that every time (or almost) I order my child supplements
they are back ordered and by the time I finally get them I have multiple cases that expire in 3 weeks
5 (38) Repeated errors […] refill not processed […]

Codes with n < 3 not shown. Percentages may not add to 100; multiple codes may be applied to each participant statement
CK creatine kinase, ER emergency room, HCP healthcare provider, PKU phenylketonuria

that care coordination during hospitalizations was poor. In
this study, at the emergency department, several participants
expressed dissatisfaction with providers/staff not following
an emergency protocol letter. There was no single common
aspect of care contributing to negative experiences during
hospitalization. We recommend further research to identify
predictors of care satisfaction, with an emphasis on factors
contributing to poor experiences in the emergency department and during hospitalization.

Consistent with our previous qualitative study [17], caregiver participants considered metabolic clinic care to be
strongly family centered, as evidenced by high scores in
most of the MPOC-20 subscales. A common recommendation to address the needs of children with chronic conditions is the identification of a ‘medical home’. While the
American Academy of Pediatrics recommends a primary
care provider as a medical home [31], for many children
with IMD, the metabolic clinic provides the treatment and
care most relevant to the health needs of the child and is thus
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Table 5  Measure of Processes of Care (MPOC) scale scores for participant perceptions of the extent of family-centered care at the metabolic
clinic in the past year, overall and stratified by key variables
Enabling and partnership

Providing general
information

Providing specific
information about the
child

Coordinated and com- Respectful and supprehensive care
portive care

N

N

Median (IQR)

N

Median (IQR)

N

Median (IQR)

N

Median (IQR)

201

4.00 (3.10)

208

5.00 (3.00)

224

5.75 (2.00)

226

6.20 (1.60)

31
162

2.60 (2.20)
4.20 (2.80)
< 0.001

32
169

3.58 (2.50)
5.67 (2.67)
< 0.001

32
184

4.00 (1.75)
6.13 (1.75)
< 0.001

32
185

4.40 (2.50)
6.40 (1.40)
< 0.001

137
61

4.00 (3.00)
3.80 (3.20)
0.530

146
59

5.33 (2.67)
5.00 (2.67)
0.058

156
65

6.00 (2.00)
5.75 (2.25)
0.127

155
67

6.40 (1.60)
5.80 (2.20)
0.062

46
51
62
34

3.90 (2.40)
4.00 (3.00)
4.40 (3.40)
3.40 (2.20)
0.507

46
55
65
35

5.17 (3.67)
5.67 (3.34)
5.50 (2.67)
4.67 (2.34)
0.234

51
60
69
36

5.75 (2.25)
6.25 (2.00)
5.75 (1.50)
5.50 (2.75)
0.386

51
59
69
38

6.60 (1.40)
6.40 (2.20)
6.00 (1.40)
5.60 (2.00)
0.336

Median (IQR)

Overall
209 6.00 (2.00)
Satisfaction with clinic carea
Non-satisfied
31
4.00 (2.33)
Satisfied
170 6.00 (2.00)
< 0.001
p valueb
Community sizec
Larger community
145 6.00 (2.00)
Smaller community 61
5.33 (2.34)
0.045
p valueb
Travel time to the metabolic clinic
< 30 min
46
6.00 (2.33)
≥ 30 min to < 1 h
57
5.67 (3.00)
≥ 1–2 h
64
6.00 (1.67)
>2h
34
5.50 (2.34)
0.348
p valued

Scores may range from 1 to 7; higher scores indicate that a provider/clinic exhibits a behavior/activity to a greater extent
IQR interquartile range
a

b
c
d

Self-reported; represents “very satisfied” and “somewhat satisfied”
Mann–Whitney U/Wilcoxon rank-sum test, two-sided normally approximated p-values
“Larger” represents “large city” and “medium-sized city”; “smaller” represents “small community” and “rural area”
Kruskal–Wallis test

a potential alternative. A medical home should have relational continuity, where the child and caregiver are familiar
with the healthcare providers and feel that they are partners in their child’s care [31]. Our results highlight this as a
strength of the metabolic clinic, which presents as a group
Table 6  Family experiences with care coordination measure scores
for community service use and coordination of healthcare in the past
year
Multiple health care service use (n=245)
No
Yes
↳ Received help to manage those multiple services (n=126)
No
Yes
No response
Source of coordination help (n=71)
Main provider’s office only
Other provider’s office only
Both main and other provider’s office
No response
Family needed/used community services (n=247)
No
Yes
↳ Access to community services (n=50)
Had trouble accessing services
Did not have trouble accessing services
a

Valid percentages reported

Proportion
No. (%a)
119 (49)
126 (51)
51 (42)
71 (58)
4
22 (32)
15 (22)
31 (46)
3
197 (80)
50 (20)
20 (40)
30 (60)

of providers familiar to and trusted by caregivers. The metabolic clinic’s familiarity with patient needs may also make
it well placed to address some of the issues at non-IMDspecific settings that caregivers identified as contributors
to negative experiences, such as problems with receiving
timely and correct products from the pharmacy.
The metabolic clinic, however, does not have all of the
recommended features of a medical home. First, while caregivers perceived strong relationships with clinic providers,
only approximately half of participants considered someone in the metabolic clinic to be their child’s main provider.
Second, ideally, a medical home coordinates a child’s care,
with active communication with other healthcare and support services [31, 32]. Participants did feel that ‘coordinated
and comprehensive care’ was provided by the metabolic
clinic to a great extent (5.75, interquartile range 2.00). Most
clinics lack providers with a defined mandate to coordinate
with other services or help families access community services. This may be reflected in participants’ ratings of the
metabolic clinic’s provision of general information (4.00,
interquartile range 3.10), indicating that care related to this
subscale was provided to only a moderate extent. Similarly,
few participants (20%) used or needed community services
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but nearly half (40%) of those users experienced trouble
accessing such services. In addition, few caregivers had
written visit summaries (32%) or shared care plans (11%)
developed by the main providers. The creation of documentation that families can use to share information with a wider
network of providers is an area where there is potential for
the metabolic clinic to play a greater role. Importantly, of
those receiving care coordination support from a provider,
nearly all (94%) were satisfied with that support, suggesting
that there may be effective existing practices that can be
replicated.
A final consideration of the metabolic clinic’s suitability
as a medical home is its accessibility. The metabolic clinic
is a specialist health service, with only 16 pediatric centers
across Canada, mostly hospital based [17]. This may present
funding and geographic challenges to service provision [33].
While more than half of participants (53%) live in large cities, participants in smaller communities may be farther away
from metabolic centers and in our exploratory analysis, we
found that these participants may be less likely to be satisfied
with metabolic care. This aligns with the literature suggesting that experiences with care may be different for residents
of small communities [27, 34]. Forty-eight percent of participants lived more than 1 h from the metabolic clinic, adding time and potentially expenses (e.g., transportation, lost
employment time) to the activity of seeking care. While we
collected data prior to the COVID-19 pandemic, interventions that have been implemented to control the pandemic
have included delivering more outpatient care via telehealth.
Understanding how this virtual care impacts families’ experiences with respect to travel time, communication with
providers, and other aspects of metabolic care is a priority
for future research. We also recommend that further studies
investigate the family centeredness of primary care and community pediatric clinics, which were identified as the main
providers for a substantial minority of participants.
This study is the first that we know of to quantitatively
survey caregivers of children across a broad range of IMD
on their experiences with healthcare interactions. It builds
on our previous qualitative work [17, 20] by quantifying
satisfaction with care across a larger sample of families and
identifying a number of potential contributors to care experiences that could be targeted for improvement. Questionnaires
were sent to all parents of children in the original cohort
study, providing a broad participant base across Canada and
strengthening generalizability. We measured satisfaction
with care at five healthcare settings common for children
with IMD, enabling contextualization within each setting’s
specific purpose and structure. This study has limitations.
Caregivers of children with intense disease management or
treatment requirements may be under-represented because
of the time required to complete the questionnaire. Most
respondents were female, with relatively high educational
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attainment and household income. This prevents us from
understanding care experiences from diverse perspectives,
including those of male caregivers and of families who may
have fewer financial resources, and therefore limits the generalizability of our findings. This was a retrospective survey
and may have been subject to recall bias. Health service use
and experiences vary by disease and disease severity [35],
as does the risk of acute exacerbations. Our sample size,
however, was too small to compare experiences by IMD.
Similarly, although healthcare is delivered differently in
different provinces and regions, we were unable to explore
geographic associations with care. In addition, this study
examined perceptions of general experiences with care, not
perceptions of individual care experiences, and the provision
of narrative data about memorable experiences was qualitative and optional. We are therefore limited in our ability
to draw conclusions about the specific aspects of care that
contribute to adverse experiences.

5 Conclusions
While participating caregivers’ satisfaction with care for
children with IMD was high, we identified important areas
where care could be improved, including care coordination and issues related to poor experiences in the emergency department and during hospitalizations. To ensure
that improvements are meaningful, we recommend further
prospective research to better understand the frequency of
adverse experiences and the common characteristics of those
experiences. This information could be used to develop
interventions to address identified gaps and improve care for
children with IMD and their families, and to further explore
a suitable medical home for children with IMD.
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